FGV Annual Report 2014

58 Adjustment to purchase price Allocation for Acquisition of Subsidiaries During the financial year, the Group completed the purchase price allocation of the assets and liabilities of subsidiaries acquired in previous financial year namely Felda Holdings Bhd. (“FHB”) and FGV Cambridge Nanosystems Limited (previously known as Cambridge Nanosystems Limited (“FGV CNS”)). The effects of prior year restatement on the Group’s financial statements are as follows: As previously reported RM’000 Effect of prior year restatement RM’000 As restated RM’000 Statements of financial position as at 31 December 2014 Property, plant and equipment 5,682,552 28,964 5,711,516 Investment properties 129,628 17,954 147,582 Intangible assets 876,261 112,255 988,516 Interest in associates 371,063 (157,945) 213,118 Interest in joint ventures 547,564 87,198 634,762 Available for sale financial assets 211,575 13,730 225,305 Inventories 1,740,099 48,400 1,788,499 Receivables (current assets) 1,351,512 25 1,351,537 Cash and cash equivalents 5,028,873 113 5,028,986 Payables (1,349,184) (43,510) (1,392,694) Deferred tax liabilities (620,192) (123,727) (743,919) Non-controlling interests (2,374,788) 16,543 (2,358,245) 59 Approval of Financial Statements The financial statements have been approved for issue in accordance with a resolution of the Board of Directors on 25 March 2015. Introduction Performance Highlights About FGV Reports Financial Statements Others Strategy and Value Creation Performance Review & Progress Foreword to Shareholders Annual General Meeting Annual Report 2014 pg 323